Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

XS-060

Copy Product Info
😃Good
Catalog No. TYD-04768Cas No. 346721-50-4
Alias XS 060

XS-060 is a potent RXRα antagonist that induces RXRα-dependent mitotic arrest by inhibiting the interaction between phosphorylated RXRα (pRXRα) and PLK1. XS-060 has demonstrated promising antitumor activity in studies of breast cancer, lung adenocarcinoma, and liver cancer.

XS-060

XS-060

Copy Product Info
😃Good
Purity: 98.80%
Catalog No. TYD-04768Alias XS 060Cas No. 346721-50-4
XS-060 is a potent RXRα antagonist that induces RXRα-dependent mitotic arrest by inhibiting the interaction between phosphorylated RXRα (pRXRα) and PLK1. XS-060 has demonstrated promising antitumor activity in studies of breast cancer, lung adenocarcinoma, and liver cancer.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$273-In Stock
10 mg$456-In Stock
25 mg$788-In Stock
50 mg$1,100-In Stock
1 mL x 10 mM (in DMSO)$298-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.80%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
XS-060 is a potent RXRα antagonist that induces RXRα-dependent mitotic arrest by inhibiting the interaction between phosphorylated RXRα (pRXRα) and PLK1. XS-060 has demonstrated promising antitumor activity in studies of breast cancer, lung adenocarcinoma, and liver cancer.
In vitro
In vitro studies indicate that XS-060 disrupt cell cycle progression by specifically targeting the pRXRα-PLK1 interaction. These compounds effectively induce RXRα-dependent mitotic arrest, inhibiting proliferation in breast, lung, and liver cancer cells. This novel mechanism involving nuclear receptor-kinase complex disruption provides a critical basis for developing potent anticancer therapies [1].
SynonymsXS 060
Chemical Properties
Molecular Weight334.37
FormulaC20H18N2O3
Cas No.346721-50-4
SmilesO=C(NN=CC1=C(O)C=CC=2C=CC=CC21)CC3=CC=C(OC)C=C3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year
Solubility Information
DMSO: 140.00 mg/mL (418.70 mM), Sonication is recommmended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.9907 mL14.9535 mL29.9070 mL149.5349 mL
5 mM0.5981 mL2.9907 mL5.9814 mL29.9070 mL
10 mM0.2991 mL1.4953 mL2.9907 mL14.9535 mL
20 mM0.1495 mL0.7477 mL1.4953 mL7.4767 mL
50 mM0.0598 mL0.2991 mL0.5981 mL2.9907 mL
100 mM0.0299 mL0.1495 mL0.2991 mL1.4953 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy XS-060 | purchase XS-060 | XS-060 cost | order XS-060 | XS-060 chemical structure | XS-060 in vitro | XS-060 formula | XS-060 molecular weight